Highlights from Stevie Wonder and the meetings of Boston and DC.
It was a week of meetings, concert, new ideas, gorgeous weather, and finding new friends–a week of quality, indeed. Here are some findings, some musings, and some encouragement to all who are seeking to build quality and safety into health outcomes.
Boston: No surprise that this beautiful city is accelerating some of the changes we want to see in health care and health outcomes. Meetings with new folks have fueled my energy in advancing the agenda in the all-important Rx development and access. What’s missing is the value of new and developing treatments in improving the total value proposition: what’s the worth in a family (quality of life during treatment), a worksite (lower absenteeism and lowering income loss), and to a person (less side effects, easier adherence, getting to cure [where possible]). Of course I’ve written about this before (Framework for Outcomes-Based Contracting, Sovaldi Value of a Cure, Sovaldi OBC Contract–Kiss is Still a Kiss), providing the business and outcomes models for using a high-cost drug that gets the person to goal. (more…)